Autopsy report · NCT02472509
The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
Cause of deathSlow enrollment
“Study not feasible - very low recruitment rate”
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 2 years 9 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Shaare Zedek Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Hemolytic Disorders; Gallstones
- Interventions
- Ursodeoxycholic Acid
- Participants
- 3
- Sites
- 1
- Countries
- Israel
Trials that died the same way
- Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
“Not enough study participants, difficulties in recruitment” - Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females
“Poor recruitment to the study” - Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
“The low recruitment rate makes it very difficult to complete the study within a reasonable period of time.” - The Effect of Ovamax on Oocyte Quality
“The study was stopped prematurely due to low recruitment rate” - Study of Fish Oil to Reduce ALT Levels in Adolescents
“Study closed for slow recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.